Capstone Partners served as exclusive financial advisor to GMD PharmaSolutions in its sale to McKesson Corporation.
GMD PharmaSolutions, a portfolio company of Hammond, Kennedy, Whitney & Company, Inc. (“HKW”), is a leading provider of specialty pharmaceuticals and related services based in Oakville, Ontario.
GMD is a market leading supplier of specialty ophthalmic pharmaceutical products requiring cold chain expertise to Canadian clinics.
McKesson Corporation (NYSE:MCK), with revenues of over $200 billion and a market capitalization of over $30 billion, is a global pharmaceutical distribution services and information technology company.
Capstone Partners’s relationship with HKW, a private equity firm founded in 1903 with offices in Indianapolis and New York, spans over 25 years.
[Capstone Partners’] healthcare services industry knowledge, experience, and relationships were instrumental in completing an attractive transaction for GMD. In hiring an investment bank, we sought a team that could best articulate GMD’s value drivers – [Capstone] exceeded our expectations in crafting a compelling investment thesis, and then engineered an extraordinary outcome with a global strategic buyer that will support management’s growth initiatives. HKW appreciates the senior commitment, expertise and collaborative approach that [Capstone] has brought to our transactions for more than 25 years.
